David Bates

4.8k total citations · 1 hit paper
35 papers, 3.5k citations indexed

About

David Bates is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, David Bates has authored 35 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in David Bates's work include Multiple Sclerosis Research Studies (9 papers), Neurological diseases and metabolism (4 papers) and Acute Ischemic Stroke Management (4 papers). David Bates is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Neurological diseases and metabolism (4 papers) and Acute Ischemic Stroke Management (4 papers). David Bates collaborates with scholars based in United Kingdom, United States and France. David Bates's co-authors include J.M. French, Helen Rodgers, J. Grimley Evans, F. CLARK, E. T. Young, F. K. E. Tunbridge, David R. Appleton, David Hasan, Mark Vanderpump and N.E.F. Cartlidge and has published in prestigious journals such as The Lancet, Nature Genetics and Brain.

In The Last Decade

David Bates

35 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey

1995 1.7k citations Mark Vanderpump, J.M. French et al. Clinical Endocrinology profile →

Peers

Countries citing papers authored by David Bates

Since Specialization

Citations

This map shows the geographic impact of David Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bates more than expected).

Fields of papers citing papers by David Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bates. The network helps show where David Bates may publish in the future.

Co-authorship network of co-authors of David Bates

This figure shows the co-authorship network connecting the top 25 collaborators of David Bates. A scholar is included among the top collaborators of David Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bates. David Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	‘The jobs all go to foreigners’: a critical discourse analysis of the Labour Party's ‘left-wing’ case for immigration controls 2022 ·Critical Discourse Studies ·David Bates	3
2	A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden 2013 ·Journal of Medical Economics ·S. Fredrikson, Euan McLeod, Nathaniel Henry, (unknown), Julia Lowin, (unknown), (unknown), (unknown), David Bates, Andrew Chan	5
3	Development and Validation of the Actionable Bladder Symptom Screening Tool for Multiple Sclerosis Patients 2013 ·International Journal of MS Care ·J. S. Burks, Michael B. Chancellor, David Bates, P. Denys, Scott MacDiarmid, Victor W. Νitti, Denise Globe, (unknown), Stacie Hudgens, Ib R. Odderson, Jalesh N. Panicker, Amy Perrin Ross	38
4	Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse 2006 ·Journal of Neuroscience Research ·(unknown), Kathryn White, Christine E. Thomson, Julia M. Edgar, David Bates, Ian R. Griffiths, Douglass M. Turnbull, (unknown)	83
5	Can somatosensory evoked potentials and neuron-specific enolase reliably predict outcome in postanoxic coma? 2006 ·Nature Clinical Practice Neurology ·David Bates	1
6	Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation 2006 ·Brain ·Patrick F. Chinnery, Douglas E. Crompton, D. Birchall, Margaret Jackson, Alan Coulthard, A. Lombès, N. Quinn, Andy J. Wills, Nicholas Fletcher, J. P. Mottershead, Paul R. Cooper, Mark Kellett, David Bates, John Burn	134
7	Disease Management in Multiple Sclerosis 2005 ·European Neurology ·David Bates, Klaus V. Toyka, Jerry S. Wolinsky, Douglas L. Arnold	1
8	Spectrum of movement disorders in neuroferritinopathy 2004 ·Movement Disorders ·Douglas E. Crompton, Patrick F. Chinnery, David Bates, Timothy J. Walls, Margaret Jackson, Andrew Curtis, John Burn	36
9	Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis 2004 ·Medical Hypotheses ·(unknown), (unknown), David Bates, Douglass M. Turnbull	67
10	Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration 2002 ·Blood Cells Molecules and Diseases ·Douglas E. Crompton, Patrick F. Chinnery, (unknown), Andrew R.J. Curtis, Christopher M. Morris, (unknown), Alastair D. Burt, (unknown), Alan Coulthard, Ann Curtis, Paul G. Ince, David Bates, Margaret Jackson, John Burn	55
11	Normokalemic periodic paralysis revisited: Does it exist? 2002 ·Annals of Neurology ·Patrick F. Chinnery, Timothy J. Walls, Michael G. Hanna, David Bates, P. Fawcett	37
12	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease 2001 ·Nature Genetics ·Andrew R.J. Curtis, (unknown), Christopher M. Morris, Laurence A. Bindoff, Paul G. Ince, Patrick F. Chinnery, Alan Coulthard, Margaret Jackson, Andrew P. Jackson, Duncan P. McHale, (unknown), William Barker, Alex Markham, David Bates, Ann Curtis, John Burn	386
13	Persistent vegetative state and brain stem death 1997 ·Current Opinion in Neurology ·David Bates	3
14	The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey breakdown → 1995 ·Clinical Endocrinology ·Mark Vanderpump, (unknown), J.M. French, David R. Appleton, David Bates, F. CLARK, J. Grimley Evans, David Hasan, Helen Rodgers, F. K. E. Tunbridge, E. T. Young	1706
15	Longitudinal study of central motor conduction time following stroke: 1. Natural history of central motor conduction 1993 ·Brain ·Andrew Heald, David Bates, N.E.F. Cartlidge, J.M. French, S. Miller	152
16	Use of the myometer in assessing stroke patients—a cautionary tale 1992 ·Disability and Rehabilitation ·Helen Rodgers, (unknown), David Bates, Oliver James	2
17	Effect of the risk factors for stroke on survival 1992 ·Neurological Research ·(unknown), JOYCE M. FRENCH, (unknown), Oliver James, David Bates	6
18	Historical Risk Factors for Stroke: A Case Control Study 1990 ·Age and Ageing ·(unknown), JOYCE M. FRENCH, (unknown), David Bates, Oliver James	38
19	Cauda equina syndrome associated with multiple lumbar arachnoid cysts in ankylosing spondylitis: improvement following surgical therapy. 1990 ·Journal of Neurology Neurosurgery & Psychiatry ·Pamela J. Shaw, D. Allcutt, David Bates, P J Crawford	22
20	PHA-induced interferon in multiple sclerosis: association between gamma interferon and clinical and genetical variables 1989 ·Acta Neurologica Scandinavica ·S.S. Papiha, J. Boddy, D. F. Roberts, David Bates	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact